17-alpha-hydroxypregnenolone has been researched along with Metabolic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GENEST, J; KOIW, E; NOWACZYNSKI, W | 1 |
1 other study(ies) available for 17-alpha-hydroxypregnenolone and Metabolic Diseases
| Article | Year |
|---|---|
URINARY EXCRETION OF DELTA-5-PREGNENE-3-BETA, 17-ALPHA, 20-ALPHA-TRIOL IN NORMAL SUBJECTS AND HYPERSENSITIVE PATIENTS.
Topics: 17-alpha-Hydroxypregnenolone; Adrenal Glands; Angiotensins; Fluids and Secretions; Humans; Hypertension; Hypertension, Malignant; Hypertension, Renal; Kidney; Metabolic Diseases; Pregnenes; Progestins; Steroids; Urine | 1964 |